Gupta Rishi Insider Trades

Insider Trading History

Track insider trading activity for Gupta Rishi. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.22M 33,989 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$966k 35,569 shares
$27.16
$36.03
Turnstone Biologics
Turnstone Biologics TSBX
Director
Holding Value $0 0 shares
Last Trade
Aug 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$1.05M 3,099,265 shares
$0.34
$0.36
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $738k 20,491 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 20,491 shares
$22.47
$36.03
Turnstone Biologics
Turnstone Biologics TSBX
10% owner
Holding Value $4.53k 12,770 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.4k 12,770 shares
$2.69
$0.36
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $276M 7,663,349 shares
Last Trade
May 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.9M 1,033,300 shares
$22.14
$36.03
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $842k 23,364 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$347k 23,364 shares
$14.85
$36.03
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $607k 16,835 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 16,835 shares
$14.85
$36.03
Turnstone Biologics
Turnstone Biologics TSBX
10% owner
Holding Value $9.07k 25,540 shares
Last Trade
Oct 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.7k 25,540 shares
$2.61
$0.36
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $312M 8,663,349 shares
Last Trade
May 17, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.5k 2,125 shares
$20.00
$36.03
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $0 0 shares
Last Trade
May 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.5k 2,125 shares
$20.00
$36.03
Imara
Imara IMRA
10% owner
Holding Value $0 0 shares
Last Trade
May 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.4k 2,125 shares
$6.32
$17.45
Imara
Imara IMRA
10% owner
Holding Value $151M 8,663,349 shares
Last Trade
May 17, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.4k 2,125 shares
$6.32
$17.45
Verona Pharma Plc
Verona Pharma Plc VRNA
Director
Holding Value $441M 4,123,091 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.22M 359,713 shares
$20.08
$106.91
Verona Pharma Plc
Verona Pharma Plc VRNA
Director
Holding Value $442M 4,137,491 shares
Last Trade
May 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$935k 43,200 shares
$21.64
$106.91
Verona Pharma Plc
Verona Pharma Plc VRNA
Director
Holding Value $447M 4,180,691 shares
Last Trade
May 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.78M 80,000 shares
$22.26
$106.91
Verona Pharma Plc
Verona Pharma Plc VRNA
Director
Holding Value $10.3M 96,000 shares
Last Trade
Apr 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.01M 96,000 shares
$20.95
$106.91
Imara
Imara IMRA
10% owner
Holding Value $481k 27,567 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 27,567 shares
$6.32
$17.45
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $993k 27,567 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$697k 27,567 shares
$25.28
$36.03
Imara
Imara IMRA
10% owner
Holding Value $133M 7,611,458 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49.9M 7,899,572 shares
$6.32
$17.45
Verona Pharma Plc
Verona Pharma Plc VRNA
Director
Holding Value $3.77B 35,294,568 shares
Last Trade
Dec 23, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.6M 2,170,368 shares
$22.84
$106.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up